Chronic fatigue syndrome (CFS) can be a debilitating condition that effects all ares of the individual’s quality of life. Since oxygen is a key driver to the body’s energy stores (ATP), it would make sense that this therapy would be of benefit. This study evaluated 16 patients diagnosed with CFS following 3 weeks of hyperbaric treatments.
The results documented improvements in all areas measured and noted that their were no complications and the treatments were well tolerated by all participants. Thus, a short 3 week duration of hyperbaric oxygen therapy could result in significant benefits for this patient population, in terms of quality of life
“This website is for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This site offers people general information and in no way should anyone consider that this site represents the practice of medicine. This site assumes no responsibility for how this material is used. Also note that this website frequently updates its contents, due to a variety of reasons. No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult with your doctor before beginning any new program”
Copyright © 2024 Hyperbaric Hub LLC All Rights Reserved
